Davern Capital Partners, LP
Filing Date
Global Rank
#3,112
/ 8,605
▲ 341
· as of Mar 2026
Top Industry
Biotechnology
71.1%
3Y Alpha vs SPY
+4.5%
Period ended 3 months ago
Filed May 14, 2026 · 56d
2 quarters · since Dec 2025
Clone Performance
Feb 2026–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+12.1%
SPY
+10.0%
Annualised alpha
+6.4%
Max drawdown
−9.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
17 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
12.3%
−4.2 pts
Top 5
45.8%
−15.3 pts
Top 10
80.7%
−10.0 pts
HHI
749
Diversified−237
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $364,540,239 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
7 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| LEGN | Legend Biotech Corp | +258,080 | 1,314,748 | $23,783,791 | |
| MLYS | Mineralys Therapeutics, Inc. | +236,505 | 447,153 | $12,113,374 | |
| IONS | Ionis Pharmaceuticals Inc | +148,426 | 386,903 | $29,052,546 | |
| NTRA | Natera, Inc. | +65,316 | 143,966 | $28,791,760 | |
| VRDN | Viridian Therapeutics, Inc.DE | +40,842 | 302,457 | $5,916,058 | |
| ABVX | Abivax S.A. | +29,623 | 78,125 | $8,699,218 | |
| LLY | ELI LILLY & Co | +18,972 | 27,279 | $25,090,405 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
6 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| PFE | Pfizer Inc | −448,300 | 1,593,942 | $44,757,891 | |
| RPRX | Royalty Pharma plc | −320,641 | 520,009 | $24,944,831 | |
| ROIV | Roivant Sciences Ltd. | −154,900 | 873,398 | $24,193,124 | |
| BNTX | BioNTech SE | −66,161 | 305,055 | $27,113,288 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −7,620 | 44,800 | $34,614,272 | |
| ARGX | Argenx SE | −640 | 35,045 | $25,591,611 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
4 positions
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CGON | CG Oncology, Inc. | 162,005 | $6,726,447 | |
| No positions match the current search. | ||||
17 positions ·
$364,540,239 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PFE |
Pfizer Inc
Healthcare
|
Reduced | 1,593,942 | $44,757,891 | 12.28% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 44,800 | $34,614,272 | 9.50% | |
| INSM |
INSMED Inc
Healthcare
|
NEW | 182,562 | $29,852,538 | 8.19% | |
| IONS |
Ionis Pharmaceuticals Inc
Healthcare
|
Added | 386,903 | $29,052,546 | 7.97% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 143,966 | $28,791,760 | 7.90% | |
| BNTX |
BioNTech SE
Healthcare
|
Reduced | 305,055 | $27,113,288 | 7.44% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 35,045 | $25,591,611 | 7.02% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Added | 27,279 | $25,090,405 | 6.88% | |
| RPRX |
Royalty Pharma plc
Healthcare
|
Reduced | 520,009 | $24,944,831 | 6.84% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 873,398 | $24,193,124 | 6.64% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
Added | 1,314,748 | $23,783,791 | 6.52% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 447,153 | $12,113,374 | 3.32% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 78,125 | $8,699,218 | 2.39% | |
| GENB |
Generate Biomedicines, Inc.
Healthcare
|
NEW | 591,800 | $7,397,500 | 2.03% | |
| PRCT |
PROCEPT BioRobotics Corp
Healthcare
|
NEW | 261,200 | $6,532,612 | 1.79% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
NEW | 126,461 | $6,095,420 | 1.67% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
Added | 302,457 | $5,916,058 | 1.62% |